The U.S. Centers for Disease Control and Prevention estimates nearly 13 million people in the U.S. have “latent TB infection.

Learn how new TB treatments show higher success rates and fewer side effects with shorter, all-oral regimens. Discover more.

The price of pretomanid, a key component used in the treatment of drug-resistant tuberculosis (TB), dropped by 25% in April, ...

Global health experts warn that US retreat from TB prevention programs could lead to a resurgence of the deadliest infectious ...

Apr. 21, 2025 — Tuberculosis ... drug regimens to fight multidrug-resistant TB. The treatments, which include recently discovered TB drugs, ... Antibiotic Treatment for Drug-Resistant ...

TB Alliance's third licensed manufacturer makes pretomanid available through the Global Drug Facility, further improving ...

The fungal infection is multidrug resistant and is most often found in hospitals and nursing homes, Missoula Public Health's Cindy Farr told NBC Montana. Statewide health officials reportedly ...

The price of pretomanid, a key component used in the treatment of drug-resistant ... an essential medicine in the fight against multidrug-resistant TB, more accessible and affordable for TB ...